Data from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Nicolás Anselmino(Hebron University), Nora M. Navone(The University of Texas MD Anderson Cancer Center), Jun Yang(The University of Texas MD Anderson Cancer Center), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Geraldine Gueron(Consejo Nacional de Investigaciones Científicas y Técnicas), Ana M. Aparicio(The University of Texas MD Anderson Cancer Center), Sumit K. Subudhi(The University of Texas MD Anderson Cancer Center), Cindy J. Lee(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Louis L. Pisters(The University of Texas MD Anderson Cancer Center), John C. Araujo(The University of Texas MD Anderson Cancer Center), John F. Ward(The University of Texas MD Anderson Cancer Center), Estefanía Labanca(The University of Texas MD Anderson Cancer Center), Paul G. Corn(Cornell University), P. Andrew Futreal(Wellcome Sanger Institute), Elba S. Vázquez(Fundación Ciencias Exactas y Naturales), Jiabin Dong(The University of Texas MD Anderson Cancer Center), Subhiksha Nandakumar(Memorial Sloan Kettering Cancer Center), Yu Chen(Guangdong Academy of Medical Sciences), Jianhua Zhang(XinHua Hospital), John W. Davis(The University of Texas MD Anderson Cancer Center), Ritika Kundra, Xiaofei Song(Jiangsu University), Peter D.A. Shepherd(The University of Texas MD Anderson Cancer Center)

Unknown

May 15, 2024

Cited by 1

|Nature|2014|6.6k

|Cell|2015|3.6k

|Nature|2009|3.5k

|Cell|2018|3.4k

|Cell|2015|3.3k

Related Papers